Lindbrook Capital, LLC Cardlytics, Inc. Transaction History
Lindbrook Capital, LLC
- $1.05 Billion
- Q1 2024
A detailed history of Lindbrook Capital, LLC transactions in Cardlytics, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 198 shares of CDLX stock, worth $1,645. This represents 0.0% of its overall portfolio holdings.
Number of Shares
198
Previous 112
76.79%
Holding current value
$1,645
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CDLX
# of Institutions
165Shares Held
35.7MCall Options Held
739KPut Options Held
1.29M-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.37MShares$53 Million8.28% of portfolio
-
Black Rock Inc. New York, NY2.87MShares$23.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.29MShares$19 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.21MShares$18.4 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY2MShares$16.6 Million2.47% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $273M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...